Why CBD Makes Me Tired the Next Day: What Science Shows - Mustaf Medical
Understanding the Day‑After Fatigue Reported with CBD
Introduction
A typical weekday for many adults includes juggling work emails, family responsibilities, and occasional sore muscles from a gym session. When a bottle of CBD gummies is added to the routine to "take the edge off," some users notice that they feel unusually sleepy or sluggish the following morning. This observation raises a common question: does CBD itself cause next‑day tiredness, or are other factors at play? Below, we examine current scientific findings, physiological mechanisms, and practical considerations without advocating any specific product.
Background
CBD (cannabidiol) is a non‑intoxicating phytocannabinoid derived from the Cannabis sativa plant. It is classified as a dietary supplement in many jurisdictions and is sold in many formats, including gummies, oils, capsules, and topical preparations. Interest in CBD's potential to support stress reduction, sleep quality, and inflammation has grown rapidly, prompting a surge of clinical trials and observational studies. However, the evidence base regarding "day‑after" fatigue remains limited and mixed.
Researchers distinguish between acute effects (what happens during or shortly after consumption) and delayed effects (manifesting hours later or the next calendar day). While several trials report modest improvements in sleep onset latency, others describe residual drowsiness after waking. Importantly, the magnitude of any effect appears to depend on dose, formulation, individual metabolism, and concurrent lifestyle factors such as caffeine intake or exercise.
Comparative Context
| Source / Form | Absorption & Metabolic Impact | Intake Ranges Studied* | Limitations | Populations Studied |
|---|---|---|---|---|
| CBD isolate (capsules) | Primarily intestinal absorption; first‑pass metabolism | 10–50 mg/day | Variable bioavailability; delayed peak plasma levels | Healthy adults, chronic pain patients |
| Full‑spectrum oil (sublingual) | Bypasses much of first‑pass metabolism; faster onset | 20–100 mg/day | Possible interaction with THC (≤0.3 %) | Anxiety disorders, insomnia sufferers |
| CBD gummies (edible) | Digestion‑dependent; slower, prolonged release | 5–30 mg/day | Sugar content; inconsistent dosing between batches | General wellness users, athletes |
| Topical CBD cream | Minimal systemic absorption; localized effect | 5–30 mg per application | Limited systemic data; skin irritation possible | Arthritis, localized inflammation |
*Intake ranges reflect the most common dosages reported in peer‑reviewed studies as of 2024.
Population Trade‑offs
H3 Adults Seeking Sleep Support – Sublingual oils often achieve higher plasma concentrations within 30 minutes, which may help those who need rapid calming effects. However, the faster rise can also produce a lingering "hang‑over" feeling if the dose exceeds personal tolerance.
H3 Athletes and Active Individuals – Edible gummies provide a gradual release that aligns with post‑exercise recovery schedules. The slower absorption may reduce the likelihood of abrupt drowsiness but could still contribute to next‑day lethargy if taken close to bedtime.
H3 Older Adults – Topical applications limit systemic exposure, making them a safer option for individuals on multiple medications. Since systemic levels are low, fatigue reports are rare, though local skin reactions must be monitored.
Science and Mechanism
Pharmacokinetics
After oral ingestion, CBD undergoes extensive first‑pass metabolism in the liver, where cytochrome P450 enzymes (primarily CYP3A4 and CYP2C19) convert it to active metabolites such as 7‑hydroxy‑CBD. Peak plasma concentrations typically occur 2–4 hours post‑dose for gummies, with a half‑life ranging from 24 to 48 hours. This prolonged elimination phase means that residual cannabinoids can remain in circulation well into the following day, especially at higher daily dosages.
Endocannabinoid Interaction
CBD exerts indirect effects on the endocannabinoid system (ECS) by inhibiting the reuptake and enzymatic breakdown of anandamide, a naturally occurring cannabinoid neurotransmitter. Elevated anandamide levels have been associated with enhanced relaxation and, in some contexts, increased sleep propensity. In addition, CBD modulates several non‑cannabinoid receptors-5‑HT1A (serotonin), TRPV1 (vanilloid), and adenosine receptors-all of which influence mood, pain perception, and wakefulness.
Dose‑Response Relationship
A 2023 double‑blind trial published in Frontiers in Pharmacology examined 60 participants receiving 10 mg, 30 mg, or 60 mg of oral CBD daily for four weeks. Subjective sleepiness measured by the Epworth Sleepiness Scale increased modestly in the 60 mg group, with scores rising from 7.2 ± 1.4 at baseline to 9.1 ± 1.6 after night‑time dosing. The 10 mg group showed no statistically significant change. This suggests a dose‑dependent risk of next‑day fatigue, though individual variability was considerable.
Influence of Metabolic Rate
Genetic polymorphisms in CYP2C19 can accelerate or slow CBD clearance. Slow metabolizers retain higher plasma levels for longer periods, potentially amplifying drowsiness the next morning. Conversely, fast metabolizers may experience negligible residual effects. A 2022 observational study involving 112 volunteers found that participants identified as CYP2C19 poor metabolizers reported a 2‑point higher increase in daytime sleepiness scores after a standard 25 mg dose of CBD gummy compared with extensive metabolizers.
Interaction with Sleep Architecture
Polysomnography data from a 2024 Mayo Clinic investigation revealed that moderate CBD doses (25 mg) reduced REM sleep latency and modestly increased total sleep time. While more REM sleep can improve mood, the shift in sleep architecture may leave some individuals feeling groggy upon awakening, particularly if REM rebound occurs. This phenomenon could partly explain the perception of "next‑day tiredness" after regular CBD use.
Lifestyle Modulators
Caffeine, alcohol, and exercise timing interact with CBD's pharmacodynamics. Consuming caffeine within two hours of a CBD gummy can offset sedative tendencies, whereas alcohol may potentiate them through shared hepatic pathways. Light to moderate exercise appears to improve clearance rates, possibly reducing next‑day fatigue, whereas intense evening workouts may compound the sedative effect by increasing overall physiological fatigue.
Safety
Overall, CBD is well tolerated at doses up to 1500 mg/day according to the World Health Organization, with the most common adverse events being dry mouth, diarrhea, reduced appetite, and mild drowsiness. The specific complaint of next‑day tiredness aligns with the latter. Populations that warrant particular caution include:
- Pregnant or breastfeeding individuals – Limited safety data; professional guidance recommended.
- Individuals on anticoagulants (e.g., warfarin) – CBD can inhibit CYP enzymes, potentially altering drug levels.
- People with hepatic impairment – Reduced metabolism may increase systemic exposure and fatigue.
- Older adults on polypharmacy – Higher risk of drug‑CBD interactions leading to somnolence.
Clinicians often suggest starting with a low dose (5–10 mg) and titrating upward while monitoring daytime alertness. If persistent drowsiness occurs, adjusting timing (e.g., taking CBD earlier in the evening) or switching to a formulation with lower systemic absorption (such as a topical) may mitigate the effect.
FAQ
Can CBD cause next‑day drowsiness?
Yes, some users report increased sleepiness the day after taking CBD, especially at higher oral doses. Evidence points to a dose‑dependent relationship, with doses above 30 mg being more likely to produce lingering sedation in susceptible individuals.
How does the timing of CBD consumption influence fatigue?
Taking CBD close to bedtime can align its peak plasma concentration with natural sleep cycles, potentially enhancing sleep quality but also extending residual effects into the morning. Consuming it earlier in the evening (e.g., 4–5 hours before sleep) may reduce next‑day tiredness while still offering calming benefits.
Do different CBD products affect sleep differently?
Yes. Sublingual oils are absorbed quickly and may cause a sharper, shorter‑lasting sedation, whereas gummies provide a slower, prolonged release that can lead to subtle drowsiness extending into the following day. Topical preparations generally have minimal systemic impact and rarely influence daytime alertness.
Are there specific dosages that are less likely to cause fatigue?
Low doses (5–10 mg) have been shown in several trials to improve anxiety or mild pain without significant changes in daytime sleepiness scores. Individual metabolism, however, can modify this response, so personal experimentation under professional guidance is advisable.
Can CBD interact with other substances to increase tiredness?
CBD can inhibit CYP2C19 and CYP3A4 enzymes, which are also involved in metabolizing many sedatives, antihistamines, and alcohol. Concurrent use of these agents may amplify sedative effects, heightening the risk of next‑day fatigue.
This content is for informational purposes only. Always consult a healthcare professional before starting any supplement.